Category: Uncategorized

Managing Risk in the “New Era”

The way companies integrate teams, build relationships with government officials, and respond to risk is changing.

/ August 14, 2020

As China Emerges from COVID-19, US Companies Invest to Compete

Solutions to short-term challenges may end up outlasting the pandemic.

/ July 24, 2020

China’s Participation in International Standards Setting: Benefits and Concerns for US Industry

Without continued vigilance by international standards-setting organizations, there is a potential for weaknesses common to the Chinese domestic system to leak in.

/ February 7, 2020

Addressing Risk in the Era of US-China “Great Power” Competition

Washington’s obsession with national security presents compliance and reputational risk to US companies in China, but they can protect against it.

/ January 13, 2020

Export Controls on Emerging and Foundational Technologies: A Null Set?

There may be less than meets the eye to Congress’s latest export controls push.

/ January 3, 2020

The Social Credit Shadow Looming Behind the Trade War

China aimed to have its comprehensive Social Credit System ready to roll out by 2020. Just a few months from that self-imposed deadline, where does the SCS stand today?

/ October 7, 2019

Adapting for China? Winning Brands Don’t Seek to be Understood, but to Understand

Lessons learned by established Western brands that have successfully adapted for the Chinese market.

/ August 26, 2019

Companies in the Crosshairs? China to Enact its own Export Controls

This summer, China announced its intention to develop two of its own export controls lists, potentially in response to actions taken by the United States. Details pending, these moves could have a profound impact on foreign investment in China.

/ August 7, 2019

Open Government Developments in China: Implications for US Businesses

The People’s Republic of China continues to modernize the Chinese regulatory state through its open government project, even as the Chinese Communist Party (CCP) asserts comprehensive leadership and tightens political and social controls under General Secretary Xi Jinping.

/ July 1, 2019

The Hidden Challenges of China’s Booming Medical AI Market

At an estimated market size of RMB 20 billion in 2018, China’s medical artificial intelligence (AI) market promises vast opportunities for US companies with innovative AI products and solutions. Yet, businesses that do not have the foresight and resources to...

/ June 24, 2019